Showing results (41-50 of 132) with videos related to

Sort By:
Pageof 14
European Journal of Pharmacology|July 18, 2006
The pituitary mediates the anxiolytic-like effects of the vasopressin V1B receptor antagonist, SSR149415, in a social interaction test in ratsToshiharu Shimazaki, Michihiko Iijima, Shigeyuki Chaki
Neuroscience Letters|December 29, 2009
Effects of agents targeting glutamatergic systems on marble-burying behaviorMichihiko Iijima, Shinsuke Kurosu, Shigeyuki Chaki
European Journal of Pharmacology|August 31, 2007
Blockade of the metabotropic glutamate 2/3 receptors enhances social memory via the AMPA receptor in ratsToshiharu Shimazaki, Ayaka Kaku, Shigeyuki Chaki
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 7, 2015
The Antidepressant Effects of an mGlu2/3 Receptor Antagonist and Ketamine Require AMPA Receptor Stimulation in the mPFC and Subsequent Activation of the 5-HT Neurons in the DRNKenichi Fukumoto, Michihiko Iijima, Shigeyuki Chaki
Behavioural Brain Research|September 15, 2007
D-Serine and a glycine transporter inhibitor improve MK-801-induced cognitive deficits in a novel object recognition test in ratsJun-Ichi Karasawa, Kenji Hashimoto, Shigeyuki Chaki
Neuroscience Letters|October 20, 2005
A metabotropic glutamate 2/3 receptor antagonist, MGS0039, increases extracellular dopamine levels in the nucleus accumbens shellJun-ichi Karasawa, Takao Yoshimizu, Shigeyuki Chaki
CNS Drug Reviews|December 4, 2003
Neuropharmacological profile of an atypical antipsychotic, NRA0562Shiho Hirota, Naoya Kawashima, Shigeyuki Chaki, et al.
The International Journal of Neuropsychopharmacology|January 9, 2018
Role of 5-HT1A Receptor Stimulation in the Medial Prefrontal Cortex in the Sustained Antidepressant Effects of KetamineKenichi Fukumoto, Michihiko Iijima, Takeo Funakoshi, et al.
Pageof 14